These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39033267)

  • 1. Clinical-epidemiological profile and factors associated with viral non-suppression in patients living with HIV/AIDS assisted at the Integrated Treatment Center at the Maputo Military Hospital (CITRA/MMH), 2019 to 2020.
    Chicanequisso EM; Baltazar CS; Sacarlal J
    BMC Infect Dis; 2024 Jul; 24(1):713. PubMed ID: 39033267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study.
    Desta AA; Woldearegay TW; Futwi N; Gebrehiwot GT; Gebru GG; Berhe AA; Godefay H
    BMC Infect Dis; 2020 Jan; 20(1):4. PubMed ID: 31898535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia.
    Ayele G; Tessema B; Amsalu A; Ferede G; Yismaw G
    BMC Immunol; 2018 Dec; 19(1):37. PubMed ID: 30558580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of viral load non-suppression among adolescents in Mbale District, Eastern Rural Uganda.
    Maena J; Banke-Thomas A; Mukiza N; Kuteesa CN; Kakumba RM; Kataike H; Kizito S; Babirye JA; Nakalega R
    AIDS Res Ther; 2021 Dec; 18(1):91. PubMed ID: 34863196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevirapine hair and plasma concentrations and HIV-1 viral suppression among HIV infected ante-partum and post-partum women attended in a mother and child prevention program in Maputo city, Mozambique.
    Cuco RM; Loquiha O; Juga A; Couto A; Meggi B; Vubil A; Sevene E; Osman N; Temermam M; Degomme O; Sidat M; Bhatt N
    PLoS One; 2022; 17(2):e0261522. PubMed ID: 35143515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics associated with viral suppression among HIV-infected children aged 0-14 years in Mozambique, 2019.
    Fataha NVFA; Gaveta S; Sacarlal J; Rossetto EV; Baltazar CS; Kellogg TA
    PLoS One; 2024; 19(7):e0305380. PubMed ID: 39024349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
    Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
    BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.
    Mhlanga TT; Jacobs BKM; Decroo T; Govere E; Bara H; Chonzi P; Sithole N; Apollo T; Van Damme W; Rusakaniko S; Lynen L; Makurumidze R
    AIDS Res Ther; 2022 Jul; 19(1):34. PubMed ID: 35810317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral load non-suppression status among women exposed to Dolutegravir-based versus Efavirenz-based regimens in Ethiopia: A before-and-after study.
    Facha W; Tadesse T; Wolka E; Astatkie A
    PLoS One; 2024; 19(6):e0305331. PubMed ID: 38857273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral suppression among pregnant adolescents and women living with HIV in rural KwaZulu-Natal, South Africa: a cross sectional study to assess progress towards UNAIDS indicators and Implications for HIV Epidemic Control.
    Ntombela NP; Kharsany ABM; Soogun A; Yende-Zuma N; Baxter C; Kohler HP; McKinnon LR
    Reprod Health; 2022 May; 19(1):116. PubMed ID: 35550580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preterm delivery and small-for-gestation outcomes in HIV-infected pregnant women on antiretroviral therapy in rural South Africa: Results from a cohort study, 2010-2015.
    Chetty T; Thorne C; Coutsoudis A
    PLoS One; 2018; 13(2):e0192805. PubMed ID: 29470508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: A retrospective cross sectional study.
    Desta AA; Wubayehu Woldearegay T; Berhe AA; Futwi N; Gebremedhn Gebru G; Godefay H
    PLoS One; 2019; 14(12):e0226293. PubMed ID: 31830095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?
    Labhardt ND; Bader J; Lejone TI; Ringera I; Puga D; Glass TR; Klimkait T
    Trop Med Int Health; 2015 Jul; 20(7):914-8. PubMed ID: 25782332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
    BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study.
    Chendi BH; Okomo Assoumou MC; Jacobs GB; Yekwa EL; Lyonga E; Mesembe M; Eyoh A; Ikomey GM
    BMC Infect Dis; 2019 Feb; 19(1):194. PubMed ID: 30808298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study.
    Chhim K; Mburu G; Tuot S; Sopha R; Khol V; Chhoun P; Yi S
    AIDS Res Ther; 2018 Nov; 15(1):20. PubMed ID: 30445984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral suppression among children and their caregivers living with HIV in western Kenya.
    Humphrey JM; Genberg BL; Keter A; Musick B; Apondi E; Gardner A; Hogan JW; Wools-Kaloustian K
    J Int AIDS Soc; 2019 Apr; 22(4):e25272. PubMed ID: 30983148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High viral suppression rates among PLHIV on dolutegravir who had an initial episode of viral non-suppression in Uganda September 2020-July 2021.
    Namayanja GA; Da Silva JF; Elur B; Nasirumbi PM; Raizes E; Ssempiira J; Nazziwa E; Nabukenya M; Sewanyana I; Balaba J; Ntale J; Calnan J; Birabwa E; Akao J; Mwangi C; Naluguza M; Ahimbisibwe A; Katureebe C; Nabadda S; Nelson L; Dirlikov E
    PLoS One; 2024; 19(6):e0305129. PubMed ID: 38923981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress towards the UNAIDS 95-95-95 targets among pregnant women in South Africa: Results from the 2017 and 2019 national Antenatal HIV Sentinel Surveys.
    Woldesenbet S; Cheyip M; Lombard C; Manda S; Ayalew K; Kufa T; Puren A
    PLoS One; 2022; 17(7):e0271564. PubMed ID: 35862306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.